open access

Vol 52, No 2 (2018)
Original research articles
Submitted: 2017-09-05
Published online: 2017-11-01
Get Citation

Central nervous involvement by chronic lymphocytic leukaemia

Dariusz Szczepanek1, Ewa Wąsik-Szczepanek2, Agnieszka Szymczyk23, Małgorzata Wach2, Maria Cioch2, Monika Podhorecka2, Ewelina Grywalska4, Marek Hus2
DOI: 10.1016/j.pjnns.2017.10.012
·
Neurol Neurochir Pol 2018;52(2):228-234.
Affiliations
  1. Department of Neurosurgery and Paediatric Neurosurgery, Medical University of Lublin, Lublin, Poland
  2. Department of Haematooncology and Bone Marrow Transplantation, Medical University of Lublin, Poland
  3. Independent Clinical Transplantology Unit, Medical University of Lublin, Poland
  4. Department of Clinical Immunology, Medical University of Lublin, Poland

open access

Vol 52, No 2 (2018)
Original research articles
Submitted: 2017-09-05
Published online: 2017-11-01

Abstract

Inclusion of the central nervous system (CNS) in the course of chronic lymphocytic leukaemia (CLL) is rare. At the moment no risk factors or proven treatment methods are known. The disease is described both in its early phase and during its acceleration period, thus it has been suggested that there might be independent mechanisms influencing the development of this condition. As there are no unified diagnostic procedure algorithms each patient needs to be assessed individually. CLL can manifest mostly in elderly people, for whom a possibility of development of neurological disorders with their aetiology different from leukaemia, should also be taken into consideration. The thesis presents a group of seven patients with CLL with CNS infiltration. Patients with prolymphocytic leukaemia, Richter's transformation and the original location of leukemic infiltration within the eye socket constitute an especially interesting case.

Abstract

Inclusion of the central nervous system (CNS) in the course of chronic lymphocytic leukaemia (CLL) is rare. At the moment no risk factors or proven treatment methods are known. The disease is described both in its early phase and during its acceleration period, thus it has been suggested that there might be independent mechanisms influencing the development of this condition. As there are no unified diagnostic procedure algorithms each patient needs to be assessed individually. CLL can manifest mostly in elderly people, for whom a possibility of development of neurological disorders with their aetiology different from leukaemia, should also be taken into consideration. The thesis presents a group of seven patients with CLL with CNS infiltration. Patients with prolymphocytic leukaemia, Richter's transformation and the original location of leukemic infiltration within the eye socket constitute an especially interesting case.

Get Citation

Keywords

Chronic lymphocytic leukaemia, Central nervous system infiltration, Intraventricular treatment

About this article
Title

Central nervous involvement by chronic lymphocytic leukaemia

Journal

Neurologia i Neurochirurgia Polska

Issue

Vol 52, No 2 (2018)

Pages

228-234

Published online

2017-11-01

Page views

280

Article views/downloads

510

DOI

10.1016/j.pjnns.2017.10.012

Bibliographic record

Neurol Neurochir Pol 2018;52(2):228-234.

Keywords

Chronic lymphocytic leukaemia
Central nervous system infiltration
Intraventricular treatment

Authors

Dariusz Szczepanek
Ewa Wąsik-Szczepanek
Agnieszka Szymczyk
Małgorzata Wach
Maria Cioch
Monika Podhorecka
Ewelina Grywalska
Marek Hus

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl